Proteins of purified Epstein-Barr virus
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Mature Epstein-Barr virus (EBV) was purified from the culture medium of infected lymphocytes made functionally conditional for Zta activation of lytic replication by an in-frame fusion with a mutant estrogen receptor. Proteins in purified virus preparations were separated by gradient gel electrophoresis and trypsin-digested; peptides were then analyzed by tandem hydrophobic chromatography, tandem MS sequencing, and MS scans. Potential peptides were matched with EBV and human gene ORFs. Mature EBV was mostly composed of homologues of proteins previously found in a herpes virion. However, EBV homologues to herpes simplex virus capsid-associated or tegument components UL7 (BBRF2), UL14 (BGLF3), and EBV BFRF1 were not significantly detected. Instead, probable tegument components included the EBV and γ-herpesvirus-encoded BLRF2, BRRF2, BDLF2 and BKRF4 proteins. Actin was also a major tegument protein, and cofilin, tubulin, heat shock protein 90, and heat shock protein 70 were substantial components. EBV envelope glycoprotein gp350 was highly abundant, followed by glycoprotein gH, intact and furin-cleaved gB, gM, gp42, gL, gp78, gp150, and gN. BILF1 (gp64) and proteins associated with latent EBV infection were not detected in virions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For compositional analysis, most studies have focused on viruses with high proteomic complexity, including those in the families Herpesviridae (4–9) and Poxviridae (10–12).”
From The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology (2014) · cites this paper as [4]
Citations
Cites
DNA sequence and expression of the B95-8 Epstein—Barr virus genome
Baer, R., Bankier, A. T., Biggin, M. D., Deininger, P. L., Farrell, P. J., Gibson, T. J., Hatfull, G., Hudson, G. S., Satchwell, S. C., Séguin, C., et al. (1984) · Nature · doi:10.1038/310207a0 · Cited by 2,053
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
Russo, J. J., Bohenzky, R. A., Chien, M.-C., Chen, J., Yan, M., Maddalena, D., Parry, J. P., Peruzzi, D., Edelman, I. S., Chang, Y., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14862 · Cited by 1,467
Three-Dimensional Structure of Herpes Simplex Virus from Cryo-Electron Tomography
Grünewald, K., Desai, P., Winkler, D. C., Heymann, J. B., Belnap, D. M., Baumeister, W., & Steven, A. C. (2003) · Science · doi:10.1126/science.1090284 · Cited by 586
Evolution of the herpesviruses
Davison, A. J. (2002) · Veterinary Microbiology · doi:10.1016/s0378-1135(01)00492-8 · Cited by 336
Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes
Li, Q., Spriggs, M. K., Kovats, S., Turk, S. M., Comeau, M. R., Nepom, B., & Hutt-Fletcher, L. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4657-4662.1997 · Cited by 319
The UL6 Gene Product Forms the Portal for Entry of DNA into the Herpes Simplex Virus Capsid
Newcomb, W. W., Juhas, R. M., Thomsen, D. R., Homa, F. L., Burch, A. D., Weller, S. K., & Brown, J. C. (2001) · Journal of Virology · doi:10.1128/jvi.75.22.10923-10932.2001 · Cited by 309
Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells
Tugizov, S. M., Berline, J. W., & Palefsky, J. M. (2003) · Nature Medicine · doi:10.1038/nm830 · Cited by 286
Proteins associated with purified human cytomegalovirus particles
Baldick, C. J., & Shenk, T. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.6097-6105.1996 · Cited by 176
Spear, G. T., Lurain, N. S., Parker, C. J., Ghassemi, M., Payne, G. H., & Saifuddin, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.9.4376 · Cited by 169
Grogan, E. A., Jenson, H. B., Countryman, J. K., Heston, L., Gradoville, L., & Miller, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1332 · Cited by 137
Research works printed but not linked: 2
- Hutt-Fletcher, L. M. & Lake, C. M. (2001) Curr. Top. Microbiol. Immunol. 258, 51-64.11443867
- Iwase, H. & Hotta, K. (1993) Methods Mol. Biol. 14, 151-159.8348231
Cited by
Items 101–200 of 450
The Epstein-Barr Virus LF2 Protein Inhibits Viral Replication
Calderwood, M. A., Holthaus, A. M., & Johannsen, E. (2008) · Journal of Virology · doi:10.1128/jvi.00315-08 · Cited by 52
“transfecting B95-8 Z-HT cells (42) with pCEP-R-HT, followed by hygromycin selection.”
MethodSelf-citationMoerdyk-Schauwecker, M. J., Hwang, S., & Grdzelishvili, V. Z. (2009) · Virology Journal · doi:10.1186/1743-422x-6-166 · Cited by 55
“8 5(8/7) HIV-1[23], VV [11], EBV [16], KSHV [20], HCMV [19], SARS-CoV [22].”
BackgroundInfluentialCharacterization of the Epstein–Barr virus glycoprotein BMRF-2
Xiao, J., Palefsky, J. M., Herrera, R., & Tugizov, S. M. (2006) · Virology · doi:10.1016/j.virol.2006.09.047 · Cited by 49
“The actual amount of BMRF-2 protein in mature virions could be much greater than that detected in our studies and those of others (Johannsen et al., 2004).”
BackgroundResultPadula, M. E., Sydnor, M. L., & Wilson, D. W. (2009) · Journal of Virology · doi:10.1128/jvi.01927-08 · Cited by 56
“There have been extensive proteomics studies for various members of the herpesvirus family, such as HCMV, Epstein-Barr virus, and Kaposi’s sarcoma-associated herpesvirus, among others (1, 14, 42).”
BackgroundChatterjee, K., Das, P., Chattopadhyay, N. R., Mal, S., & Choudhuri, T. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e02624 · Cited by 55
Virion Factors That Target Daxx To Overcome Intrinsic Immunity
Schreiner, S., & Wodrich, H. (2013) · Journal of Virology · doi:10.1128/jvi.00425-13 · Cited by 52
“tegument proteins in the EBV virion, and it plays an essential role in establishing viral latent infection (40, 41).”
BackgroundThe Epstein-Barr Virus BMRF1 Gene Is Essential for Lytic Virus Replication
Neuhierl, B., & Delecluse, H. (2006) · Journal of Virology · doi:10.1128/jvi.80.10.5078-5081.2006 · Cited by 47
“Since BMRF1 cannot be detected in the mature virion (11), it is unlikely to play a role in the early stages of immortalization either.”
BackgroundChromatin Structure of Epstein–Barr Virus Latent Episomes
Lieberman, P. M. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-22822-8_5 · Cited by 52
“Mass-spectrometry and proteomic studies of EBV virions fail to detect histone proteins (Johannsen et al. 2004).”
BackgroundYen, C., Lu, M., Tzeng, C., Huang, J., Chang, H., Chen, R.-S., Liu, S.-Y., Liu, S., Shieh, B., & Li, C. L. (2009) · BioMed Research International · doi:10.1155/2009/904589 · Cited by 46
“Importantly, the genes fabricated at the spots 61 (BBRF1, BBRF2, and BBRF3) and 68 (BDLF4 and BDRF1) on EBV-chip were actively expressed in a significantly greater number of OSCC exhibiting exophytic morphology or ulceration than those tissues with deep invasive lesions (P = .0265 and .0141, resp.).”
Characterization of EBV gB indicates properties of both class I and class II viral fusion proteins
Backović, M., Leser, G. P., Lamb, R. A., Longnecker, R., & Jardetzky, T. S. (2007) · Virology · doi:10.1016/j.virol.2007.06.031 · Cited by 45
“In EBV virions, the majority of gB is found in a cleaved form that contains a 78 kDa N-terminal fragment and a 58 kDa C-terminal fragment, and a small fraction of the total gB is uncleaved (Johannsen et al., 2004).”
BackgroundEpstein-Barr Virus BKRF4 Gene Product Is Required for Efficient Progeny Production
Masud, H. M. A. A., Watanabe, T., Yoshida, M., Sato, Y., Goshima, F., Kimura, H., & Murata, T. (2017) · Journal of Virology · doi:10.1128/jvi.00975-17 · Cited by 45
“Other viral lytic proteins (BZLF1, BALF2, BMRF1, BALF4, and BRRF2) were expressed at almost equal levels in the knockout virus compared to wild type (Fig.”
BackgroundMethodInfluentialLi, D., Fu, W., & Swaminathan, S. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007070 · Cited by 45
Herpesviruses: overview of systematics, genomic complexity and life cycle
Dotto-Maurel, A., Arzul, I., Morga, B., & Chevignon, G. (2025) · Virology Journal · doi:10.1186/s12985-025-02779-7 · Cited by 59
“These proteins are distributed as follows: 4 to 7 in the nucleocapsid, 9 to 20 in the tegument and 4 to 19 in the envelope plus a number of proteins whose location within virions is unknown [8, 38–42].”
Multiple Functions for ORF75c in Murid Herpesvirus-4 Infection
Gaspar, M., Gill, M. B., Lösing, J.-B., May, J. S., & Stevenson, P. G. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002781 · Cited by 48
Whitehurst, C. B., Li, G., Montgomery, S. A., Montgomery, N. D., Su, L., & Pagano, J. S. (2015) · mBio · doi:10.1128/mbio.01574-15 · Cited by 44
“Although BPLF1 is a late lytic gene, it is also present in the viral tegument (55, 56) and could affect early processes during infection that may influence B-cell transformation.”
BackgroundPrice, A. M., Messinger, J. E., & Luftig, M. A. (2017) · Journal of Virology · doi:10.1128/jvi.01178-17 · Cited by 44
“The B95-8 strain of Epstein-Barr virus was produced from the B95-8 Z-HT cell line as previously described (54).”
MethodSelf-citationDeng, B., O’Connor, C. M., Kedes, D. H., & Zhou, Z. H. (2007) · Journal of Virology · doi:10.1128/jvi.02254-06 · Cited by 44
“Based on sequence comparison and mass spectrometry studies of purified virions, gammaherpesviruses also contain a portal protein (PORT), which is encoded by ORF43 in KSHV or its rhesus homolog (14) and by BBRF1 in Epstein-Barr virus (9).”
BackgroundNevels, M. M., Nitzsche, A., & Paulus, C. (2011) · Reviews in Medical Virology · doi:10.1002/rmv.690 · Cited by 50
Chiu, Y., Sugden, B., Chang, P., Chen, L.-W., Lin, Y.-J., Lan, Y., Lai, C., Liou, J.-Y., Liu, S., & Hung, C. (2012) · Journal of Virology · doi:10.1128/jvi.01126-12 · Cited by 43
“present in the tegument layer of EBV (21).”
BackgroundHo, T., Sitz, J., Shen, Q., Leblanc-Lacroix, A., Campos, E. I., Borozan, I., Marcon, E., Greenblatt, J. F., Fradet‐Turcotte, A., Jin, D., et al. (2018) · Journal of Virology · doi:10.1128/jvi.00262-18 · Cited by 45
“the EBV proteins that consistently inhibited the formation of 53BP1 foci was a tegument protein (32).”
BackgroundChromatinisation of herpesvirus genomes
Paulus, C., Nitzsche, A., & Nevels, M. M. (2009) · Reviews in Medical Virology · doi:10.1002/rmv.632 · Cited by 47
“E-mail: michael.nevels@klinik. uni-regensburg.de Abbreviations used ASF1, anti-silencing function 1; ATRX, -thalassemia/mental retardation syndrome X-linked protein; BGLF4, EBV BamHI G left frame 4 protein; BHV-1, bovine herpesvirus type 1; BRG1, Brahma-related gene 1 protein; BRM, Brahma protein; BZLF1, EBVBamHI Z le…”
BackgroundInfluentialFeederle, R., Mehl-Lautscham, A. M., Bannert, H., & Delecluse, H. (2009) · Journal of Virology · doi:10.1128/jvi.00525-09 · Cited by 42
Role of the TSG101 Gene in Epstein-Barr Virus Late Gene Transcription
Chua, H., Lee, H., Chang, S.-S., Lu, C., Yeh, T., Hsu, T.-Y., Cheng, T.-H., Cheng, J., Chen, M., & Tsai, C.-H. A. (2006) · Journal of Virology · doi:10.1128/jvi.02289-06 · Cited by 44
“BILF2 encodes gp78/55, an N-linked glycoprotein, and also is detectable in the envelope of EBV virions (29, 47).”
BackgroundFeederle, R., Neuhierl, B., Baldwin, G., Bannert, H., Hub, B., Mautner, J., Behrends, U., & Delecluse, H. (2006) · Journal of Virology · doi:10.1128/jvi.00473-06 · Cited by 42
“BNRF1 has been shown to be part of the infectious virus, but its function during viral infection is unknown (3, 11).”
BackgroundInfluentialGenome-Wide Analysis of Epstein-Barr Virus Rta DNA Binding
Heilmann, A. M. F., Calderwood, M. A., Portal, D., Lu, Y. C., & Johannsen, E. (2012) · Journal of Virology · doi:10.1128/jvi.06760-11 · Cited by 41
“The B95-8 Z-HT cell line was derived by stable expression of Z-HT in the EBV-transformed cotton-top tamarin cell line B95-8 as previously described (42) and was cultured in RPMI 1640 medium (Gibco) supplemented with L-glutamine, penicillin-streptomycin, and 10% FetalPlex.”
MethodSelf-citationIsolating the Epstein-Barr Virus gp350/220 Binding Site on Complement Receptor Type 2 (CR2/CD21)
Young, K. A., Chen, X. S., Holers, V. M., & Hannan, J. P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706324200 · Cited by 47
Carter, C. (2011) · Journal of Pathogens · doi:10.4061/2011/128318 · Cited by 45
“EEF2 Elongation factor 2 Epstein Barr [111]”
Chesnokova, L. S., Ahuja, M. K., & Hutt‐Fletcher, L. M. (2014) · Journal of Virology · doi:10.1128/jvi.01597-14 · Cited by 39
“This antibody, however, could recognize by Western blotting both the full-length uncleaved gB, which is found in virions (37), and the carboxyterminal fragment of gB, which is cleaved by furins in the cell in which it is made (38) (Fig.”
BackgroundEpstein–Barr Virus Acquires Its Final Envelope on Intracellular Compartments With Golgi Markers
Nanbo, A., Noda, T., & Ohba, Y. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00454 · Cited by 40
“In a previous study, mature EBV was found to incorporate viral and host proteins identified by tandem mass spectrometry (Johannsen et al., 2004).”
BackgroundEncyclopedia of EBV-Encoded Lytic Genes: An Update
Murata, T. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-7230-7_18 · Cited by 40
Proteomic Analysis of Pathogenic and Attenuated Alcelaphine Herpesvirus 1
Dry, I., Haig, D. M., Inglis, N. F., Imrie, L., Stewart, J. P., & Russell, G. C. (2008) · Journal of Virology · doi:10.1128/jvi.00094-08 · Cited by 40
“Furthermore, identification of gp42 was not dependent on deglycosylation of the EBV virion prior to analysis (15).”
BackgroundMethodInfluentialTanaka, M., Sata, T., & Kawaguchi, Y. (2008) · Virology Journal · doi:10.1186/1743-422x-5-125 · Cited by 39
“The UL7 amino acid sequence is conserved in all Herpesviridae subfamilies [2], suggesting that UL7 homologues may play conserved roles in the herpes virus life cycle.”
BackgroundGillen, J., Li, W., Liang, Q., Avey, D. R., Wu, J., Wu, F., Myoung, J., & Zhu, F. (2015) · Journal of Virology · doi:10.1128/jvi.02925-14 · Cited by 45
“Despite the differences, ORF45 85 homologues have been identified as virion protein components in all gamma herpesviruses 86 examined so far, including RRV, MHV-68, and EBV, suggesting that certain tegument functions 87 of ORF45 are conserved (19-24).”
BackgroundCharacterization of Proprotein Convertases and Their Involvement in Virus Propagation
Garten, W. (2018) · Springer eBooks · doi:10.1007/978-3-319-75474-1_9 · Cited by 45
Forrest, C., Hislop, A. D., Rickinson, A. B., & Zuo, J. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007110 · Cited by 39
“It is nevertheless striking that other abundant virion proteins such as the large tegument protein BPLF1 and the major envelope protein BLLF1 (gp350) [35] were rarely if ever seen as targets for CD8+ memory T cell responses in the present work or, for gp350, in earlier peptide screens [16, 48].”
BackgroundInfluentialdel Rio, T., DeCoste, C. J., & Enquist, L. W. (2005) · Journal of Virology · doi:10.1128/jvi.79.13.8614-8619.2005 · Cited by 39
“ously shown to be a major tegument protein of Epstein-Barr virus (18).”
BackgroundBatisse, J., Manet, É., Middeldorp, J. M., Sergeant, A., & Gruffat, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.14102-14111.2005 · Cited by 39
“Accordingly, EBV BcLF1, BDLF1, BORF1, BFRF3, BVRF2, BdRF1, BBRF1, and BVRF1 ORFs are likely to encode, respectively, the major capsid protein (MCP), minor capsid protein (mCP), the mCP-binding protein (mCP-BP), the smallest capsid protein (sCP), the protease (Pr), the protease-assemblin (Pr/ AP), the portal protein, a…”
BackgroundBortz, E., Wang, L., Jia, Q., Wu, T.-T., Whitelegge, J. P., Deng, H., Zhou, Z., & Sun, R. (2007) · Journal of Virology · doi:10.1128/jvi.01233-06 · Cited by 38
“MHV-68 ORF52 is an abundant virion protein (6), as are its homologues in KSHV (with which it shares 28% identity) (55), EBV (BLRF2; 40% identity) (23, 38), and RRV (32).”
BackgroundInfluentialZhao, B., Zhang, X., Krummenacher, C., Song, S., Gao, L., Zhang, H., Xu, M., Feng, L., Feng, Q., Zeng, M., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00932 · Cited by 39
“Despite being the most abundant EBV glycoprotein on virions (23), this glycosylation pattern suggests that native gp350 remains monomeric since its important glycan coverage may prevent protein-protein interaction on the viral envelope (22).”
BackgroundChakravorty, A. “., Sugden, B., & Johannsen, E. (2019) · Journal of Virology · doi:10.1128/jvi.02247-18 · Cited by 44
“because EBV DNA in virions is unmethylated and is packaged without histones (48), the”
BackgroundSelf-citationZheng, D., Wan, J., Cho, Y. G., Wang, L., Chiou, C.-J., Pai, S. G., Woodard, C. L., Zhu, J. K., Liao, G., Martı́nez-Maza, O., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir645 · Cited by 38
“Seven EBV antigens were consistently recognized by IgA across these patient groups, namely, EBNA1, the helicase BBLF4, the viral IL10 BCRF1, the uracil DNA glycoslyase BKRF3, the early protein BRRF1, the tegument protein BRRF2 [40] , and the latency membrane protein LMP2A ( Figure 6 ).”
BackgroundLi, X., & Zhu, F. (2008) · Journal of Virology · doi:10.1128/jvi.02209-08 · Cited by 37
“ORF45 homologues have been identified as virion protein components in other gammaherpesviruses, such as Epstein-Barr virus (EBV), rhesus rhadinovirus (RRV), and murine herpesvirus 68 (MHV-68), suggesting that certain tegument functions of ORF45 are conserved (2, 11, 18).”
BackgroundAlbright, E. R., & Kalejta, R. F. (2016) · Journal of Virology · doi:10.1128/jvi.01220-16 · Cited by 40
Histone Loaders CAF1 and HIRA Restrict Epstein-Barr Virus B-Cell Lytic Reactivation
Zhang, Y., Jiang, C., Trudeau, S. J., Narita, Y., Zhao, B., Teng, M., Guo, R., & Gewurz, B. E. (2020) · mBio · doi:10.1128/mbio.01063-20 · Cited by 39
“packaging into viral particles evade histone loading, since histones are not detectable in purified EBV viral particles (86).”
BackgroundJean-Pierre, V., Lupo, J., Buisson, M., Morand, P., & Germi, R. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.701611 · Cited by 37
Global Approaches To Study Protein–Protein Interactions Among Viruses and Hosts
Mendez-Rios, J. D., & Uetz, P. (2010) · Future Microbiology · doi:10.2217/fmb.10.7 · Cited by 37
El-Guindy, A. S., López‐Giráldez, F., Delecluse, H., McKenzie, J., & Miller, G. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004307 · Cited by 36
“BVRF1 is a tegument protein and is a homolog of HSV UL25 (cork), BILF1 is a virally encoded G protein coupled receptor, and BMRF2 is a transmembrane envelope protein [59,60,61].”
BackgroundRüdiger, A.-T., Mayrhofer, P., Ma‐Lauer, Y., Pohlentz, G., Müthing, J., von Brunn, A., & Schwegmann‐Weßels, C. (2016) · Virology · doi:10.1016/j.virol.2016.07.022 · Cited by 37
“Moreover, tubulin was already found packaged into virions of Epstein-Barr virus, human cytomegalovirus, and murine leukemia virus (Johannsen et al., 2004; Varnum et al., 2004; Wang et al., 2003).”
BackgroundOda, S., Arii, J., Koyanagi, N., Kato, A., & Kawaguchi, Y. (2016) · Journal of Virology · doi:10.1128/jvi.01258-16 · Cited by 35
Limited nucleotide pools restrict Epstein–Barr virus-mediated B-cell immortalization
Hafez, A. Y., Messinger, J. E., McFadden, K., Fenyőfalvi, G., Shepard, C., Lenzi, G. M., Kim, B., & Luftig, M. A. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.46 · Cited by 36
Self-citationReyda, S., Tenzer, S., Navarro, P., Gebauer, W., Saur, M., Krauter, S., Büscher, N., & Plachter, B. (2014) · Journal of Virology · doi:10.1128/jvi.01415-14 · Cited by 41
“Interestingly, a number of Rabs, but not Rab43, were found to be associated with virions of other herpesviruses (58, 60, 61, 63).”
BackgroundZhang, C., Xue, C., Li, Y., Kong, Q., Ren, X., Li, X., Shu, D., Bi, Y., & Cao, Y. (2010) · Virology Journal · doi:10.1186/1743-422x-7-242 · Cited by 36
“Some stress proteins, such as Hsp70 and Hsp90 are components for purified EBV virions and may regulate actin filament formation [28].”
BackgroundStructural basis underlying viral hijacking of a histone chaperone complex
Huang, H., Deng, Z., Vladimirova, O. V., Wiedmer, A., Lu, F. Y., Lieberman, P. M., & Patel, D. J. (2016) · Nature Communications · doi:10.1038/ncomms12707 · Cited by 35
Technologies for Proteome-Wide Discovery of Extracellular Host-Pathogen Interactions
Martinez-Martín, N. (2017) · Journal of Immunology Research · doi:10.1155/2017/2197615 · Cited by 36
“Although these analyses suffer from several drawbacks associated with membrane protein characterization, particularly the poor solubility of these proteins and the low abundance of many plasma membrane proteins, these studies have revealed a complex composition for most of the viruses studied, alongside incorporation…”
Cai, M., Liao, Z., Chen, T., Wang, P., Zou, X., Wang, Y., Xu, Z., Jiang, S. W., Huang, J., Chen, D., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.19549 · Cited by 35
“Protein name(s) Function/description # COS-7 subcellular localization Literature localization and references 13 EBNA1 l (BKRF1) Latency nuclear antigen 1, assures EBV episome maintenance replication, Gly-rich domain, essential for immortalization Pan-nuclear Nuclear a/b [55] 14 BLLF3 n dUTP pyrophosphatase, dUTPase, h…”
BackgroundInfluentialKato, A., Oda, S., Watanabe, M., Oyama, M., Kozuka‐Hata, H., Koyanagi, N., Maruzuru, Y., Arii, J., & Kawaguchi, Y. (2018) · Journal of Virology · doi:10.1128/jvi.01035-18 · Cited by 34
Regulation of Human Cytomegalovirus Secondary Envelopment by a C-Terminal Tetralysine Motif in pUL71
Read, C., Schauflinger, M., Nikolaenko, D., Walther, P., & von Einem, J. (2019) · Journal of Virology · doi:10.1128/jvi.02244-18 · Cited by 35
Modulation of Innate Immune Signaling Pathways by Herpesviruses
Liu, Q., Rao, Y., Tian, M., Zhang, S. J., & Feng, P. (2019) · Viruses · doi:10.3390/v11060572 · Cited by 39
Epstein–Barr virus BDLF2–BMRF2 complex affects cellular morphology
Lösing, J.-B., Fiore, S. D., Ritter, K., Fischer, R., & Kleines, M. (2009) · Journal of General Virology · doi:10.1099/vir.0.009571-0 · Cited by 39
“, 1984), is described as a component of the EBV virion tegument (Johannsen et al., 2004).”
BackgroundInfluentialConserved tegument protein complexes: Essential components in the assembly of herpesviruses
Diefenbach, R. J. (2015) · Virus Research · doi:10.1016/j.virusres.2015.09.007 · Cited by 33
Bencun, M., Klinke, O. K., Hotz‐Wagenblatt, A., Klaus, S., Tsai, M., Poirey, R., & Delecluse, H. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky129 · Cited by 33
“Both the proteome of EBV purified virus particles that contain large amounts of viral proteins, and the proteome of replicating cells are available, but this does not give information on the viral translation process itself (16,17).”
BackgroundStructural Rearrangement within an Enveloped Virus upon Binding to the Host Cell
Meckes, D. G., & Wills, J. W. (2008) · Journal of Virology · doi:10.1128/jvi.01223-08 · Cited by 34
“In contrast, the UL16 homologs of beta- and gammaherpesviruses have been found to be mostly capsid associated even in the absence of NEM in similar types of experiments (21, 47, 52).”
ResultGore, M. L., & Hutt‐Fletcher, L. M. (2008) · Virology · doi:10.1016/j.virol.2008.10.010 · Cited by 33
“…al., 2004; Molesworth et al., 2000; Oda et al., 2000) nor fusion (McShane and Longnecker, 2004), implying a role perhaps similar to that of the ORF27/ORF58 complex of MHV-68, one that has been suggested to be compatible with the low level detection of BMRF2 in the virion (Johannsen et al., 2004).”
BackgroundMethodInfluentialRegulated Interaction of Tegument Proteins UL16 and UL11 from Herpes Simplex Virus
Chadha, P., Han, J., Starkey, J. L., & Wills, J. W. (2012) · Journal of Virology · doi:10.1128/jvi.01879-12 · Cited by 32
“UL16(1-155)-GFP or its corresponding cysteine mutants were”
BackgroundMethodInfluentialDeciphering Novel Host–Herpesvirus Interactions by Virion Proteomics
Lippé, R. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00181 · Cited by 35
“Similarly, studies focusing on PRV and EBV reported up to 48 and 43 cellular proteins, respectively (Johannsen et al., 2004; Kramer et al., 2011).”
BackgroundInfluentialIdentification and localization of the structural proteins of anguillid herpesvirus 1
van Beurden, S. J., Leroy, B., Wattiez, R., Haenen, O. L. M., Boeren, S. A., Vervoort, J. J. M., Peeters, B. P. H., Rottier, P. J. M., Engelsma, M. Y., & Vanderplasschen, A. F. C. (2011) · Veterinary Research · doi:10.1186/1297-9716-42-105 · Cited by 34
“This number resembles the total number of structural proteins reported for members of the Herpersviridae family [18-25].”
Electron Tomography of Nascent Herpes Simplex Virus Virions
Baines, J. D., Hsieh, C., Wills, E. G., Mannella, C. A., & Marko, M. (2007) · Journal of Virology · doi:10.1128/jvi.02571-06 · Cited by 33
“Actin is a strong candidate given the presence of actin in herpesvirions, the association of F actin with capsids in infected-cell nuclei, and the dependence of active intranuclear movement of capsids on actin (3, 10, 11, 13, 14, 25, 50).”
BackgroundOlotu, F. A., & Soliman, M. E. S. (2021) · Biomedical Journal · doi:10.1016/j.bj.2020.01.002 · Cited by 35
“Required for efficient nuclear transport of Triplex protein 2 (TRX2) Early lytic/structural P03187 364 [18]”
BackgroundInfluentialLiu, C., Chen, Y., Min, Y.-L., Zhao, B., Cheng, C., Kang, M.-S., Chiu, S.-J., Kieff, E. D., & Peng, C. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1003084 · Cited by 32
“EBV infectious particles were induced and purified from the B95-8 Z-HT cell line as previously described [49].”
MethodSelf-citationMilbradt, J., Sonntag, E., Wagner, S., Strojan, H., Wangen, C., Roviš, T. L., Lisnić, B., Jonjić, S., Sticht, H., Britt, W. J., et al. (2018) · Viruses · doi:10.3390/v10010035 · Cited by 31
Human herpesvirus portal proteins: Structure, function, and antiviral prospects
Kornfeind, E. M., & Visalli, R. J. (2018) · Reviews in Medical Virology · doi:10.1002/rmv.1972 · Cited by 32
“Tandem mass spectrometry studies of purified EBV virions identified a putative portal protein homolog encoded by BBRF1.(149) Although the EBV portal has not yet been characterized, an EBV ΔBBRF1 mutant was unable to package viral genomes.”
BackgroundResearch landmarks on the 60th anniversary of Epstein-Barr virus
Zhong, L., Xie, C., Zhang, L., Yang, Y.-L., Liu, Y.-T., Zhao, G., Bu, G., Tian, X.-S., Jiang, Z., Yuan, B., et al. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2766-0 · Cited by 39
“Eleven glycoproteins are dispersed on the surface of the EBV virion (Hutt-Fletcher, 2015; Johannsen et al., 2004).”
Lam, W. K., Kang, G., Chan, C. M. L., Lee, V. C. T., Ma, M.-J. L., Zhou, Q. X., Jiang, P., Tse, I. O. L., King, A. D., Wong, K. C. W., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.02.002 · Cited by 37
BGLF2 Increases Infectivity of Epstein-Barr Virus by Activating AP-1 upon De Novo Infection
Konishi, N., Narita, Y., Hijioka, F., Masud, H. M. A. A., Sato, Y., Kimura, H., & Murata, T. (2018) · mSphere · doi:10.1128/msphere.00138-18 · Cited by 31
“because BGLF2 protein is in the tegument component (19) and can enhance BZLF1”
MASS SPECTROMETRY IN VIROLOGICAL SCIENCES
Milewska, A., Ner‐Kluza, J., Dąbrowska, A., Bodzoń‐Kułakowska, A., Pyrć, K., & Suder, P. (2019) · Mass Spectrometry Reviews · doi:10.1002/mas.21617 · Cited by 36
“…MS‐based approaches including human cytomegalovirus (CMV), Epstein‐Barr virus (EBV), Kaposi’s sarcoma‐ associated herpesvirus (KSHV), and several animal herpesviruses (Baldick & Shenk, 1996; Bortz et al., 2003; Johannsen et al., 2004; Kattenhorn et al., 2004; Varnum et al., 2004; Zhu et al., 2005).”
MethodRecent advances in the activation and regulation of the cGAS-STING pathway
Fang, R., Jiang, Q., Yu, X., Zhao, Z., & Jiang, Z. (2022) · Advances in immunology · doi:10.1016/bs.ai.2022.09.003 · Cited by 32
Epstein-Barr Virus LF2 Protein Regulates Viral Replication by Altering Rta Subcellular Localization
Heilmann, A. M. F., Calderwood, M. A., & Johannsen, E. (2010) · Journal of Virology · doi:10.1128/jvi.00573-10 · Cited by 31
Self-citationProteomic analysis of purified coronavirus infectious bronchitis virus particles
Kong, Q., Xue, C., Ren, X., Zhang, C., Li, L., Shu, D., Bi, Y., & Cao, Y. (2010) · Proteome Science · doi:10.1186/1477-5956-8-29 · Cited by 35
“Proteins enriched at the virus budding sites including HSP70, HSP90 and GAPDH are also identified in IBV and other viruses [9,11,12,14,19,24].”
BackgroundNogalski, M. T., Podduturi, J. P., DeMeritt, I. B., Milford, L. E., & Yurochko, A. D. (2007) · Journal of Virology · doi:10.1128/jvi.02382-06 · Cited by 32
“Because the mass spectrometry analysis of EBV did not identify CKII in the EBV virion (34), it appears that CKII is only incorporated into HCMV virions and, thus, important only in the infection cycle of this herpesvirus.”
MethodProteomic composition of Nipah virus-like particles
Vera-Velasco, N. M., García‐Murria, M. J., del Pino, M. M. S., Mingarro, I., & Martínez‐Gil, L. (2017) · Journal of Proteomics · doi:10.1016/j.jprot.2017.10.012 · Cited by 34
He, H., Luo, M., Cao, Y.-L., Lin, Y., Zhang, H., Zhang, X., Ou, J.-Y., Yu, B., Chen, X., Xu, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19259-x · Cited by 30
Recruitment of Herpes Simplex Virus Type 1 Immediate-Early Protein ICP0 to the Virus Particle
Maringer, K., & Elliott, G. (2010) · Journal of Virology · doi:10.1128/jvi.00126-10 · Cited by 31
“In addition to virus-encoded proteins, human cytomegalovirus (hCMV), Epstein-Barr virus (EBV), Kaposi’s sarcoma-associated herpesvirus (KSHV), and HSV-1 have all been shown to package a wide range of cellular proteins into their teguments (25, 32, 49, 54).”
BackgroundNuss, J. E., Kehn‐Hall, K., Benedict, A., Costantino, J. A., Ward, M., Peyser, B. D., Retterer, C. J., Tressler, L. E., Wanner, L. M., McGovern, H. F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093483 · Cited by 34
Cai, J., Zhang, B., Li, Y., Zhu, W., Akihisa, T., Li, W., Kikuchi, T., Liu, W., Feng, F., & Zhang, J. (2021) · Vaccines · doi:10.3390/vaccines9111290 · Cited by 33
Okazaki, K. (2007) · Journal of General Virology · doi:10.1099/vir.0.82610-0 · Cited by 29
“In fact, a recent study demonstrated that Epstein–Barr virus abundantly expresses cleaved gB on its extracellular particles (Johannsen et al., 2004), although virus-infected cells contain the uncleaved form (Gong et al.”
BackgroundResultInfluentialMachiels, B., Lété, C., de Fays, K., Mast, J., Dewals, B. G., Stevenson, P. G., Vanderplasschen, A. F. C., & Gillet, L. (2010) · Journal of Virology · doi:10.1128/jvi.01092-10 · Cited by 29
Analysis of Epstein-Barr Virus Glycoprotein B Functional Domains via Linker Insertion Mutagenesis
Reimer, J. J., Backović, M., Deshpande, C. G., Jardetzky, T. S., & Longnecker, R. (2008) · Journal of Virology · doi:10.1128/jvi.01817-08 · Cited by 29
“cleavage product is similar in size to the 58 kDa C-terminal gB fragment found in EBV virions, which was suggested to be generated by cleavage at the putative furin cleavage site in EBV gB (31).”
BackgroundResultCharacterization and Role of Lentivirus-Associated Host Proteins
Kolegraff, K. N., Boštík, P., & Ansari, A. A. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100303 · Cited by 29
Stahl, J. A., Chavan, S. S., Sifford, J. M., MacLeod, V., Voth, D. E., Edmondson, R. D., & Forrest, J. C. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003583 · Cited by 28
“Six of the MHV68 phosphoproteins we identified [ORF8/gB, ORF21/TK, ORF25/major capsid protein (MCP), ORF27/gp48, ORF39/gM, and ORF45] correspond to homologous phosphoproteins present in purified EBV virions [42].”
BackgroundSong, J.-M., Choi, C.-W., Kwon, S., Compans, R. W., Kang, S., & Kim, S. I. (2011) · Journal of Proteome Research · doi:10.1021/pr200086v · Cited by 33
Wu, J., Avey, D. R., Li, W., Gillen, J., Fu, B., Miley, W., Whitby, D., & Zhu, F. (2015) · Journal of Virology · doi:10.1128/jvi.02738-15 · Cited by 30
“logues in RRV and EBV were detected in virions (16, 58).”
BackgroundKlupp, B. G., Granzow, H., Karger, A., & Mettenleiter, T. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.21.13442-13453.2005 · Cited by 27
“The subviral localization of the HCMV and EBV homologous proteins has so far not been determined.”
BackgroundInfluentialMolecular Interactions of Epstein-Barr Virus Capsid Proteins
Wang, W., Chang, L.-K., & Liu, S. (2010) · Journal of Virology · doi:10.1128/jvi.01565-10 · Cited by 27
“GST fusion proteins that contained segments of BDLF1 from amino acids 1 to 112 [GST-D(1-112)], 105 to 207 [GST-D(105-207)], and 201 to 302 [GST-D(201-302)] were used to delineate the regions in BDLF1 that interacted with VCA and BORF1.”
BackgroundMethodInfluentialEpstein-Barr Virus Protein Kinase BGLF4 Targets the Nucleus through Interaction with Nucleoporins
Chang, C.-W., Lee, C., Huang, Y.-H., Yang, P., Wang, J.-T., & Chen, M. (2012) · Journal of Virology · doi:10.1128/jvi.01058-12 · Cited by 33
“deletion from aa 1 to 26), d(1-70), and d(27-70), C-terminal deletion”
BackgroundMethodInfluentialTree Shrew Is a Suitable Animal Model for the Study of Epstein Barr Virus
Xia, W., Chen, H., Feng, Y., Shi, N., Huang, Z., Feng, Q., Xu, J., He, G., Xie, M., Lai, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.789604 · Cited by 39
“The viral supernatant was stored at −80° C until tree shrew infection (75).”
MethodDuarte, M., Wang, L., Calderwood, M. A., Adelmant, G., Ohashi, M., Roecklein‐Canfield, J. A., Marto, J. A., HILL, D. E., Deng, H., & Johannsen, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053512 · Cited by 24
“Characterization of BLRF2 during EBV Replication To characterize endogenous BLRF2 complexes during EBV replication, FLAG-HA-BLRF2 was stably expressed in EBV positive P3HR1-ZHT Burkitt Lymphoma cells [12].”
BackgroundInfluentialSelf-citationMounce, B. C., Tsan, F. C., Droit, L., Kohler, S., Reitsma, J. M., Cirillo, L. A., & Tarakanova, V. L. (2011) · Virology · doi:10.1016/j.virol.2011.08.019 · Cited by 27
Regulation of the Epstein-Barr virus Zp promoter in B lymphocytes during reactivation from latency
McDonald, C., Karstegl, C. E., Kellam, P., & Farrell, P. J. (2009) · Journal of General Virology · doi:10.1099/vir.0.017277-0 · Cited by 33
Dowell, A. C., Haigh, T. A., Ryan, G. B., Turner, J. E., Long, H. M., & Taylor, G. S. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1010137 · Cited by 26
“Proteomic analysis has identified 33 different structural proteins within purified EBV virions which could potentially be used for this vaccine strategy [27].”
BackgroundA DNA tumor virus globally reprograms host 3D genome architecture to achieve immortal growth
Wang, C., Liu, X., Liang, J., Narita, Y., Ding, W., Li, D., Zhang, L., Wang, H., Leong, M. M., Hou, I., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37347-6 · Cited by 29
Metadata
- Authors
- Johannsen, E., Luftig, M., Chase, M. R., Weicksel, S., Cahir-McFarland, E., Illanes, D., Sarracino, D., & Kieff, E.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Kieff, Elliott
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-11-08
- Volume
- 101
- Issue
- 46
- Pages
- 16286-16291
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC528973
- OpenAlex
- W2080385928
- Cited by
- 450
- References
- 35
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 31 · 2023: 31 · 2022: 21 · 2021: 15 · 2020: 23 · 2019: 19 · 2018: 25 · 2017: 18 · 2016: 20 · 2015: 26 · 2014: 19 · 2013: 13 · 2012: 19
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Leukemia and Lymphoma Society
- National Institutes of Health (5k08ai049943-02)
- National Cancer Institute (CA47006, CA 85180, R35CA047006, P01CA087661, R01CA047006, R01CA085180, CA87661)
- National Institute of Allergy and Infectious Diseases (1K-08 AI49943-03)
- Topics
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Keywords
- Epstein-Barr virus, tegument proteins, envelope glycoprotein, lytic replication, actin, cofilin, heat shock proteins, latent infection
- MeSH terms
- Chromatography, Liquid, Clone Cells, Herpesvirus 4, Human, Humans, Lymphocytes, Microscopy, Electron, Phosphorylation, Mass Spectrometry, Viral Envelope Proteins, Viral Proteins, Virus Replication, Open Reading Frames, Capsid Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.